YalePharma Securities
Investment Ltd (YSI) -
Strategic Investments
Group is part of Yalepharma,
which discovers, develops
and markets leading prescription
medicines for humans and
animals and many of the
world's best known consumer
brands. YSI invests in
companies that develop
or market technologies,
products or services that
could advance Yalepharma’s
commercial interests and
that may dramatically
change the dynamics involved
in commercializing pharmaceutical
products. While our primary
objectives are strategic
in nature, the potential
for strong financial returns
is one of the key selection
criteria we use in making
our investment decisions.
Areas of specific interest
to us include health care
devices, health care information
technology and health
care services. YSI will
not invest in companies
engaged in research or
development of human pharmaceuticals,
vaccines or consumer health
care products, since there
are other groups at Yalepharma
that work with those companies.
